2025 - Redefining Women’s Cancer Care: Delivering Smarter, Safer Clinical Trials

While mortality rates from cancer have declined rapidly in the last 30 years, cancer incidence rates among women are steadily increasing1. Breast, cervical, and ovarian are among the most common forms of cancer to affect women worldwide, and substantial unmet needs exist in their treatment. With recent diagnostic advances and the introduction of novel medicines, there is renewed interest and hope for progress in developing more effective gynecological and breast cancer treatments.
Success in bringing more effective treatments to market depends on designing studies that prioritize patient safety and experience. This involves tailoring recruitment strategies and trial environments to reflect the unique perspectives and needs of women.
In this webinar, we will discuss ways to enhance both patient recruitment and patient satisfaction, through a focus on safety monitoring, reducing trial burden, overcoming screening delays, providing proper training for sites, and using patient-reported outcomes as endpoints.
Register for this webinar today to explore innovative approaches to enhancing clinical trials for breast and gynecological cancers.
1 American Cancer Society. Cancer Facts & Figures 2025.  Atlanta: American Cancer Society; 2025.
Keywords: Cancer, Drug Development, Breast Cancer, Lung Cancer, Clinical Research, CRO, Oncology, Cancer Research, Cancer Immunotherapy, Therapeutic Areas, Cancer Drugs, Women's Health, Cancer Drug